|
Sign In to gain access to subscriptions and/or personal tools.
|
Gadolinium:Nonionic Contrast Media (1:1) Coronary Angiography in Patients With Impaired Renal Function
Tamer Sayin, MD
Ankara University Department of Cardiology, Heart Center, Turkey, tamsay{at}hotmail.com
Sibel Turhan, MD
Ankara University Department of Cardiology, Heart Center, Turkey
Ömer Akyürek, MD
Ankara University Department of Cardiology, Heart Center, Turkey
Mustafa Kilickap, MD
Ankara University Department of Cardiology, Heart Center, Turkey
This study was to test safety and efficacy of 1:1 mixture of gadolinium:nonionic contrast media in avoiding contrast nephropathy during coronary angiography in patients with renal dysfunction. Although "off label" for x-ray angiography, gadolinium has drawn attention for its potential to avoid contrast nephropathy during coronary angiography. Initial data seem promising. Patients with a baseline creatinine of 1.5 mg/dl or more were included. In order to minimize contrast nephropathy risk, all patients were thoroughly hydrated and treated by N-acetylcysteine. After coronary angiography and/or percutaneous coronary intervention, renal function tests were remeasured on days 1, 2, and 3. A rise of 0.5 mg/dl or more in creatinine value in the following 3 days or the need for dialysis were considered as a contrast nephropathy event. Twenty-six patients were enrolled in this study. Ten were women and 16 were men. The mean age was 65.7 ± 11. Baseline creatinine value was 2.47 ± 0.74 mg/dl. The total amount of contrast medium used on 1:1 fashion was 57.1 ± 27.2 ml. No procedure-related cardiac complication or contrast nephropathy event occurred in this study. Although there was a slight loss in image quality, we felt that the results were adequate for interpretation. Although "off label," using gadolinium contrast media in a 1:1 mixture with standard nonionic low osmolar contrast media seems to be a viable option in decreasing the likelihood of contrast nephropathy. Further evaluation appears to be warranted.
References
- Rihal CS, Textor SC, Grill DE, et al: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259-2264, 2002.[Abstract/Free Full Text]
- Best PJ, Lennon R., Ting HH, et al: The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39:1113-1119, 2002.[Abstract/Free Full Text]
- Shlipak MG, Heidenreich PA, Noguchi H., Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137:555-562, 2002.[Abstract/Free Full Text]
- Solomon R.: Contrast-medium-induced acute renal failure. Kidney Int 53:230-242, 1998.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bartholomew BA, Harjai KJ, Dukkipati S., et al: Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93:1515-1519, 2004.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Heyman SN, Rosen S.: Dye-induced nephropathy. Semin Nephrol 23:477-485, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sharma SK, Kini A.: Effect of non ionic radiocontrast agents on the occurrence of contrast induced nephropathy in patients with mild-moderate chronic renal insufficiency. Cathet Cardiovasc Intervent 65:386-393, 2005.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gemery J., Idelson B., Reid S., et al: Acute renal failure after arteriography with a gadolinium based contrast agent. AJR Am J Roentgenol 171:1277-1278, 1998.[Free Full Text]
- Thomsen HS: Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol 14:1654-1656, 2004.[Web of Science][Medline]
[Order article via Infotrieve]
- Bokhari SW, Wen Yhj, Winters RJ: Gadolinium based percutaneous coronary intervention in a patient with renal insufficiency. Cath Cardiovasc Intervent 58:358-361, 2003.[CrossRef]
- Rieger J., Sitter T., Toepfer M., Linsenmaier U., Pfeifer KJ, Schiffl H.: Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant 17:824-828, 2002.[Abstract/Free Full Text]
- Sarkis A., Badaoui G., Azar R., Sleilaty G., Bassil R., Jebara VA: Gadolinium enhanced coronary angiography in patients with impaired renal function. Am J Cardiol 91:974-975, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ailawadi G., Stanley JC, Williams DM, Dimick JB, Henke PK, Upchurch GR Jr: Gadolinium as a non-nephrotoxic contrast agent for catheter based arteriographic evaluation of renal arteries in patients with azotemia. J Vasc Surg 37:346-52, 2003.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Duong MH, MacKenzie TA, Malenka DJ: N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast induced nephropathy: Comprehensive meta analysis. Cath Cardiovasc Intervent 6:471-479, 2005.
- Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976.[Web of Science][Medline]
[Order article via Infotrieve]
- Badiola CM: Use of a mixture of gadolinium and iodinated contrast for angiography. Cardiovasc Intervent Radiol 27:148-150, 2004.[Web of Science][Medline]
[Order article via Infotrieve]
This version was published on November
1, 2007
Angiology, Vol. 58, No. 5,
561-564 (2007)
DOI: 10.1177/0003319707303640
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
